Edition:
India

MetLife Inc (MET.N)

MET.N on New York Stock Exchange

39.34USD
20 Oct 2020
Change (% chg)

$0.27 (+0.69%)
Prev Close
$39.07
Open
$39.56
Day's High
$40.09
Day's Low
$39.30
Volume
1,142,055
Avg. Vol
1,599,866
52-wk High
$53.27
52-wk Low
$22.86

Latest Key Developments (Source: Significant Developments)

Metlife Says Executive Vice President And President Of Latin America Region Oscar Schmidt Will Retire
Thursday, 15 Oct 2020 

Oct 15 (Reuters) - MetLife Inc ::METLIFE ANNOUNCES SENIOR LEADERSHIP CHANGES.EXECUTIVE VICE PRESIDENT AND PRESIDENT OF LATIN AMERICA REGION OSCAR SCHMIDT WILL RETIRE.SCHMIDT WILL STEP AWAY FROM HIS EXECUTIVE POSITION ON DECEMBER 31, 2020.SUCCEEDING CLURFAIN AS EXECUTIVE VICE PRESIDENT AND CHAIRMAN, PRESIDENT AND CEO OF METLIFE JAPAN K.K. WILL BE DIRK OSTIJN.METLIFE-SUCCEEDING SCHMIDT AS REGIONAL PRESIDENT, LATIN AMERICA, WILL BE ERIC CLURFAIN.SUCCEEDING OSTIJN AS HEAD OF EMEA WILL BE NURIA GARCIA, SENIOR VICE PRESIDENT AND DEPUTY HEAD OF EMEA.  Full Article

Metlife To Acquire Versant Health, Owner Of Davis Vision And Superior Vision
Thursday, 17 Sep 2020 

Sept 17 (Reuters) - MetLife Inc ::METLIFE TO ACQUIRE VERSANT HEALTH, OWNER OF DAVIS VISION AND SUPERIOR VISION.METLIFE INC - DEAL FOR APPROXIMATELY $1.675 BILLION.METLIFE INC - DEAL FOR ALL-CASH TRANSACTION.METLIFE INC - ACQUIRING 100% OF VERSANT HEALTH FROM PRIVATE INVESTOR GROUP.METLIFE INC - DEAL EXPECTED TO BE ACCRETIVE TO EPS AND FREE CASH FLOW.METLIFE INC - TO ACQUIRE VERSANT HEALTH FROM AN INVESTOR GROUP LED BY CENTERBRIDGE PARTNERS AND INCLUDING FFL PARTNERS.METLIFE INC - TRANSACTION IS TARGETED TO CLOSE IN Q4.METLIFE INC - DEAL TO BE FINANCED WITH CASH ON HAND; EXPECT TO COMPLETE CURRENT BUYBACK AUTHORIZATION BY YEAR-END 2020.  Full Article

Metlife Says Q2 Earnings Per Share $0.07
Thursday, 6 Aug 2020 

Aug 5 (Reuters) - Metlife::METLIFE INC - ‍​QTRLY EARNINGS PER SHARE $0.07; QTRLY ADJUSTED EARNINGS PER SHARE $0.83.METLIFE INC - ‍​QTRLY ADJUSTED EARNINGS, EXCLUDING TOTAL NOTABLE ITEMS $0.83 PER SHARE.METLIFE INC - ‍​QTRLY PREMIUMS, FEES AND OTHER REVENUE $10.49 BILLION. DOWN 13%.METLIFE INC - ‍​QTRLY NET INVESTMENT INCOME $4.09 BILLION, DOWN 13%.METLIFE INC - ‍​QTRLY TOTAL REVENUE $14.10 BILLION, DOWN 19%; QTRLY TOTAL ADJUSTED REVENUE $13.85 BILLION, DOWN 16%.METLIFE INC - ‍​QUARTER-END BOOK VALUE OF $78.65 PER SHARE, UP FROM $64.61 PER SHARE AT JUNE 30, 2019.METLIFE INC - ‍​QTRLY ROE 0.4% VERSUS 11.6%; QTRLY ADJUSTED ROE, EXCLUDING AOCI OTHER THAN FCTA 6.4% VERSUS 12.1%.  Full Article

Metlife Sets Quarterly Dividend Of $0.46 Per Share
Thursday, 9 Jul 2020 

July 8 (Reuters) - MetLife Inc ::SETS QUARTERLY DIVIDEND OF $0.46PER SHARE.  Full Article

Metlife Reports Qtrly Adj. Shr $1.58
Thursday, 7 May 2020 

May 6 (Reuters) - Metlife Inc ::METLIFE - QTRLY EARNINGS PER SHARE $4.75; QTRLY ADJUSTED. EARNINGS PER SHARE $1.58; QTRLY ADJUSTED. EARNINGS PER SHARE, EXCLUDING NOTABLE ITEMS $1.58.METLIFE - QTRLY PREMIUMS, FEES AND OTHER REVENUE $11.34 BILLION, UP 1%.METLIFE - QTRLY NET INVESTMENT INCOME $3.06 BILLION, DOWN 38%.METLIFE SAYS QUARTER-END BOOK VALUE OF $72.62 PER SHARE, UP 25% FROM $58.06 PER SHARE AT MARCH 31, 2019.METLIFE - QTRLY REVENUE $18.31 BILLION, UP 12%.Q1 EARNINGS PER SHARE VIEW $1.44, REVENUE VIEW $16.29 BILLION -- REFINITIV IBES DATA.$5.3 BILLION OF CASH AND LIQUID ASSETS HELD AT HOLDING COMPANY LEVEL AT MARCH 31.METLIFE’S NEXT DEBT MATURITY IS DEC. 2022, WHEN $500 MILLION OF SENIOR NOTES WILL MATURE.EXPECT NEGATIVE RETURNS IN Q2 FROM PRIVATE EQUITY.EXPECT TO ACHIEVE 12.3% DIRECT EXPENSE RATIO TARGET FOR FY 2020.UNDER Q2 OUTLOOK SAYS CHALLENGING FACE-TO-FACE GLOBAL SALES ENVIRONMENT.AVERAGE FCF TARGET RATIO OF 65-75% HOLDS FOR 2019-2020 BASED ON MARKET CONDITIONS.AVERAGE FCF RATIO ESTIMATED TO BE 40-60% FOR 2020-2021 BASED ON MARKET CONDITIONS.  Full Article

MetLife Increases Common Stock Dividend By 4.5%
Wednesday, 29 Apr 2020 

April 28 (Reuters) - MetLife Inc ::METLIFE INCREASES COMMON STOCK DIVIDEND BY 4.5 PERCENT.METLIFE INC - DECLARED A Q2 2020 COMMON STOCK DIVIDEND OF $0.46 PER SHARE.  Full Article

METLIFE EXEC SAYS UNREST IN CHILE HAD NO SIGNIFICANT IMPACT ON INSURER IN JANUARY- CONF CALL
Thursday, 6 Feb 2020 

Feb 6 (Reuters) - MetLife Inc ::EXEC SAYS UNREST IN CHILE HAD NO SIGNIFICANT IMPACT ON INSURER IN JANUARY- CONF CALL.EXEC SAYS INSURER IS ACCELERATING SOME EARLY 2020 RATE INCREASE EFFORTS IN PROPERTY & CASUALTY BUSINESS DUE TO BODILY INJURY SEVERITY - CONF CALL.EXEC SAYS INSURER IS LOOKING AT UNDERWRITING AND CLAIMS PRACTICES IN P&C BUSINESS - CONF CALL.EXEC SAYS INSURER EXPECTS TO REMAIN IN LINE WITH OVERALL GUIDANCE OF 93% TO 98% RANGE FOR AUTO BUSINESS, BUT TOWARD UPPER END - CONF CALL.  Full Article

Metlife Says Q4 Earnings Per Share $0.58
Thursday, 6 Feb 2020 

Feb 5 (Reuters) - MetLife Inc ::METLIFE - QTRLY EARNINGS PER SHARE $0.58; QTRLY ADJUSTED EARNINGS PER SHARE $1.98; QTRLY ADJUSTED EARNINGS PER SHARE EXCLUDING NOTABLE ITEMS $1.53.METLIFE - QTRLY PREMIUMS, FEES AND OTHER REVENUE $13.76 BILLION, UP 24%.METLIFE - QTRLY NET INVESTMENT INCOME $4.64 BILLION, UP 34%.METLIFE - QUARTER-END BOOK VALUE OF $68.62 PER SHARE, UP 33% FROM $51.53 PER SHARE AT DECEMBER 31, 2018.METLIFE - QTRLY TOTAL REVENUE $17.14 BILLION, UP 9%; QTRLY TOTAL ADJUSTED REVENUE $18.15 BILLION, UP 18%.Q4 EARNINGS PER SHARE VIEW $1.38, REVENUE VIEW $16.82 BILLION -- REFINITIV IBES DATA.  Full Article

MetLife Sets Quarterly Dividend Of $0.44 Per Share
Wednesday, 8 Jan 2020 

Jan 7 (Reuters) - MetLife Inc ::SETS QUARTERLY DIVIDEND OF $0.44 PER SHARE.  Full Article

Metlife Sees 2020 Corporate & Other Adjusted Loss Of $650 Mln to $750Mln After-Tax - Presentation
Thursday, 12 Dec 2019 

Dec 11 (Reuters) - MetLife Inc ::METLIFE INC - SEES 2020 CORPORATE & OTHER ADJUSTED LOSS OF $650 MILLION - $750 AFTER-TAX - PRESENTATION.METLIFE INC - SEES 2020 VARIABLE INVESTMENT INCOME OF $900 MILLION - $1.1 BILLION - PRESENTATION.METLIFE INC - IN THE NEAR TERM, SEES ADJUSTED RETURN ON EQUITY OF 12%-14% - PRESENTATION.METLIFE INC - IN THE NEAR TERM, SEES FREE CASH FLOW RATIO OF 65%-75% OF ADJUSTED EARNINGS - PRESENTATION.  Full Article

Photo

MetLife to buy PE-backed Versant Health for $1.68 billion

Insurer MetLife Inc said on Thursday it will buy vision-care benefits company Versant Health for $1.68 billion from an investor group led by Centerbridge Partners and FFL Partners, to strengthen its vision insurance business.